Vascular Events In Noncardiac Surgery Patients Cohort Evaluation Study (VISION)

Sponsor
McMaster University (Other)
Overall Status
Completed
CT.gov ID
NCT00512109
Collaborator
Roche Diagnostic Ltd. (Industry), Heart and Stroke Foundation of Ontario (Other), Population Health Research Institute (Other), Ministry of Research, Innovation and Science, Ontario (Other), Hamilton Health Sciences Corporation (Other), CLARITY Group (Other)
40,060
8
88
5007.5
56.9

Study Details

Study Description

Brief Summary

The investigators' study has 4 primary objectives. Among patients undergoing noncardiac surgery the investigators will determine: (1) the incidence of major perioperative vascular events; (2) the optimal clinical model to predict major perioperative vascular events; (3) the proportion of patients with perioperative myocardial infarctions that may go undetected without perioperative troponin monitoring; and (4) the relationship between postoperative troponin measurements and the 1 year risk of vascular death.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The increase in elderly patients undergoing surgery, the change in the invasiveness of some surgical interventions, limitations in the methodology and generalizability of previous research, and the VISION Pilot Study results highlight uncertainty about the current incidence of major vascular events and the optimal clinical risk estimation model to predict these events in patients undergoing noncardiac surgery. There is promising but inconclusive preliminary evidence that troponin measurements after surgery may allow physicians to avoid missing perioperative myocardial infarctions and may predict mortality and major vascular events in the first year following surgery. These considerations provide the impetus for the large, adequately powered, multicentre, international, prospective cohort study.

    We will determine the incidence of major vascular events, the optimal clinical model to predict major perioperative vascular events, and the extent to which troponin measurements post surgery can identify myocardial infarctions that are likely to go unrecognized and predict vascular death at 1 year. We call this study the Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION) Study.

    The VISION Study is a prospective cohort study of 40,000 patients who are > 45 years of age, undergoing noncardiac surgery requiring overnight hospital admission, and receiving a general or regional anesthetic. Hospitals (including both university and non-university hospitals) in several countries around the world will recruit patients, over a 2 year period. Study personnel will evaluate patients prior to surgery, follow patients throughout their hospitalization, and contact patients at 30 days and 1 year after surgery. All patients will have troponin T measured post surgery and on the first, second, and third days after surgery. Outcome adjudicators will adjudicate all major vascular events without knowledge of a patient's vascular risk factors.

    We will also determine if there are associations between any preoperative or postoperative medications and major perioperative vascular events. We will also determine if there are associations between any medications started after a major perioperative vascular event and vascular mortality 1 year after surgery. We will evaluate the 1 year risk of stroke in patients who do and do not develop atrial fibrillation after surgery and if there is an association with antiplatelet or warfarin therapy. We will measure N-terminal prohormone brain natriuretic peptide (NT-proBNP) in 8,000 - 10,000 patients prior to surgery and determine if NT-proBNP is an independent predictor of major perioperative vascular events. We will determine the incidence of perioperative new acute renal failure requiring dialysis and pneumonia and develop models to predict these events.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    40060 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Study
    Study Start Date :
    Aug 1, 2007
    Actual Primary Completion Date :
    Dec 1, 2014
    Actual Study Completion Date :
    Dec 1, 2014

    Outcome Measures

    Primary Outcome Measures

    1. For our first objective (i.e., the incidence of major perioperative vascular events) our primary outcome is major vascular events (i.e., a composite of vascular death, nonfatal myocardial infarction, nonfatal cardiac arrest, and nonfatal stroke) [30 days post surgery.]

    Secondary Outcome Measures

    1. For our second objective (i.e., the optimal clinical model to predict major perioperative vascular events) our primary and only outcome is major vascular events. [30 days after surgery.]

    2. For our third objective (i.e., proportion of patients with perioperative myocardial infarctions that may go undetected without perioperative troponin monitoring) our outcome is myocardial infarction that probably or possibly would have gone undetected [30 days after surgery.]

    3. For our fourth objective (i.e., the relationship between postoperative troponin measurements and the 1 year risk of vascular death) our outcomes are vascular death, and major vascular events (i.e., vascular death, MI, cardiac arrest, stroke) [1 year after surgery.]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All patients who undergo noncardiac surgery are eligible if they are > 45 years of age and receive a general or regional anesthetic (i.e., plexus block, spinal, or epidural).
    Exclusion Criteria:
    • We will exclude patients undergoing noncardiac surgery who do not require at least an overnight hospital admission after surgery or who only receive infiltrative (i.e., local) or topical anesthesia.

    • We will also exclude patients previously enrolled in the VISION Study and patients who do not consent to participate.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Instituto de Ensino e Pesquisa do Hospital do Coração (IEP-HCor) São Paulo SP Brazil 04005-000
    2 Health Science Centre, McMaster University Hamilton Ontario Canada L8N 3Z5
    3 Saint Joseph's Healthcare Hamilton Ontario Canada L8N 4A6
    4 Prince of Wales Hospital Hong-Kong China
    5 Universidad Autónoma de Bucaramanga Bucaramanga Santander Colombia
    6 St. John's Medical College Bangalore India
    7 Hospital: University Malaya Kuala Lumpur Malaysia 50603
    8 Centro Cochrane Iberoamericano. Hospital de la Santa Creu i Sant Pau Barcelona Spain 08041

    Sponsors and Collaborators

    • McMaster University
    • Roche Diagnostic Ltd.
    • Heart and Stroke Foundation of Ontario
    • Population Health Research Institute
    • Ministry of Research, Innovation and Science, Ontario
    • Hamilton Health Sciences Corporation
    • CLARITY Group

    Investigators

    • Principal Investigator: Philip J Devereaux, MD, PhD, McMaster University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    McMaster University
    ClinicalTrials.gov Identifier:
    NCT00512109
    Other Study ID Numbers:
    • VISIONAUG2/2007
    First Posted:
    Aug 7, 2007
    Last Update Posted:
    Apr 24, 2018
    Last Verified:
    Mar 1, 2016
    Keywords provided by McMaster University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 24, 2018